Literature DB >> 19667265

Fatal cystic change of brain metastasis after response to gefitinib in non-small-cell lung cancer.

Ying-Kiat Zee1, Tan-Min Chin, Alvin S C Wong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667265     DOI: 10.1200/JCO.2009.22.4501

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era.

Authors:  Elisa De Carlo; Elisa Bertoli; Alessandro Del Conte; Brigida Stanzione; Eleonora Berto; Alberto Revelant; Michele Spina; Alessandra Bearz
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

2.  Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer.

Authors:  Yi-Bing Xu; Yiping Zhang; Zhengbo Song; Wenxian Wang; Lan Shao
Journal:  Cancer Manag Res       Date:  2021-08-10       Impact factor: 3.989

Review 3.  Oral Targeted Therapies and Central Nervous System (CNS) Metastases.

Authors:  Michael P Gabay; Scott M Wirth; Joan M Stachnik; Colleen L Overley; Katie E Long; Linda R Bressler; John L Villano
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

Review 4.  Tyrosine Kinase Inhibitor Therapy for Brain Metastases in Non-Small-Cell Lung Cancer: A Primer for Radiologists.

Authors:  C Dodson; T J Richards; D A Smith; N H Ramaiya
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-26       Impact factor: 3.825

5.  Progressive multiple cystic changes in both lungs in a patient treated with gefitinib for lung adenocarcinoma with multiple lung metastases.

Authors:  Yon Ju Ryu; Eun Mi Chun; Soon Nam Lee; Sung Shin Shim
Journal:  Korean J Radiol       Date:  2014-03-07       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.